Thomas Bender is a management entity listed as a director on 2 SEC Form D filings by 1 issuer between Jan 2015 and Jul 2017: Allegro Ophthalmics, LLC (San Juan Capistrano, CA — pharmaceuticals — 2015–2017; $20.3M reported sold to 17 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Hampar Karageozian (2 shared filings), John Park (2 shared filings), Robert Byrnes (2 shared filings), Vicken Karageozian (2 shared filings), Lisa Karageozian (1 shared filing) and 6 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 10 bankruptcy cases matching the name listed in Key records below.
What this means 11 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Thomas Bender and found 5 differences: Bankruptcy case: David Thomas Bender; Bankruptcy case: Michael Thomas Bender; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.